Truist maintains Buy rating and $70 target on Silgan Holdings stock

Published 16/04/2025, 15:16
Truist maintains Buy rating and $70 target on Silgan Holdings stock

On Wednesday, Truist Securities reiterated a Buy rating and a $70.00 price target on Silgan Holdings (NYSE:SLGN), a company known for its dispensing and specialty closures. According to InvestingPro, the company maintains a "GOOD" overall financial health score and has consistently raised its dividend for 21 consecutive years, demonstrating strong operational stability. Truist Securities highlighted Silgan’s strong execution and its recent acquisition of Weener Packaging (NYSE:PKG) in October 2024 as key factors for the positive outlook.

Silgan Holdings has been recognized for its ability to secure a larger share of new product launches, especially in the high-end dispensing segment. The acquisition of Weener Packaging is seen as a strategic move that could lead to "significant cross-pollination opportunities," potentially enhancing the company’s product offerings and intellectual property portfolio. With the company’s next earnings report due on April 23, investors following InvestingPro insights can track how this acquisition impacts its $5.8 billion revenue base.

The analyst from Truist Securities pointed out that Silgan stands to gain from new opportunities in the healthcare and pharmaceutical sectors, areas where Weener Packaging has established a presence. Additionally, Silgan’s ongoing efforts to reduce costs are expected to contribute further to the company’s financial performance, which already shows a healthy gross profit margin of 17.3% and strong free cash flow generation.

In terms of valuation, Silgan Holdings is currently trading at approximately 8.5 to 9.0 times its projected 2025 Street EBITDA (earnings before interest, taxes, depreciation, and amortization) and about 10.0 to 10.5 times Truist Securities’ 2025 recession scenario EBITDA. This is compared to the historical average of around 9.0 to 9.5 times EBITDA.

The reiteration of the Buy rating and the $70.00 price target by Truist Securities reflects confidence in Silgan Holdings’ market positioning and its ability to continue delivering strong financial results.

In other recent news, Silgan Holdings reported its fourth-quarter 2024 earnings, surpassing expectations with an operating earnings per share (EPS) of $0.85, compared to the forecasted $0.83. The company maintained its revenue forecast, reporting $1.41 billion in sales, which aligns with expectations. For 2025, Silgan projects an EPS range of $4.00 to $4.20, indicating a 13% increase at the midpoint, alongside a 15% growth in free cash flow, reaching $450 million. Truist Securities upgraded the stock target for Silgan to $70, maintaining a Buy rating, citing strong performance and alignment with their positive outlook.

The company’s acquisition of Weener is expected to contribute approximately $50 million of incremental EBIT, with cost reduction efforts projected to yield around $30 million in savings. Silgan’s strategic initiatives, including the successful acquisition of Vayner Packaging, have been highlighted as key factors in its robust financial performance. The company is also anticipating growth in its Dispensing and Specialty Closures segment, with expected increases in volumes and EBIT in Metal Containers and Custom Containers. These developments reflect Silgan’s consistent execution of growth strategies and its position as a leading player in its sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.